These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7848362)

  • 1. Pharmacokinetic studies of benzalazine.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1381-3. PubMed ID: 7848362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single and subacute local and systemic toxicity studies of benzalazine.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1353-6. PubMed ID: 7848356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental studies on the pharmacokinetics and toxicity of 5-aminosalicylic acid-O-sulfate following local and systemic application.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1995 Mar; 45(3):300-3. PubMed ID: 7741789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-six-week oral toxicity study of benzalazine in rats.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1357-62. PubMed ID: 7848357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenicity studies of benzalazine in mice and rats.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1371-81. PubMed ID: 7848361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive toxicity studies of benzalazine in rats and rabbits.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1368-70. PubMed ID: 7848360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro/in vivo evaluation of 5-aminosalicyl-glycine as a colon-specific prodrug of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim YM
    J Pharm Sci; 2000 May; 89(5):594-602. PubMed ID: 10756325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon-specific prodrugs of 5-aminosalicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid.
    Jung YJ; Lee JS; Kim YM
    J Pharm Sci; 2001 Nov; 90(11):1767-75. PubMed ID: 11745734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aminosalicylic acid containing drugs. Delivery, fate, and possible clinical implications in man.
    Christensen LA
    Dan Med Bull; 2000 Feb; 47(1):20-41. PubMed ID: 10709142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic uptake of 5-aminosalicylic acid from olsalazine and eudragit L coated mesalazine in patients with ulcerative colitis in remission.
    Ewe K; Becker K; Ueberschaer B
    Z Gastroenterol; 1996 Apr; 34(4):225-9. PubMed ID: 8686349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-six-week oral toxicity study of benzalazine in dogs.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1362-5. PubMed ID: 7848358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery and fate of oral mesalamine microgranules within the human small intestine.
    Layer PH; Goebell H; Keller J; Dignass A; Klotz U
    Gastroenterology; 1995 May; 108(5):1427-33. PubMed ID: 7729635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity studies of benzalazine.
    Herzog R; Leuschner J
    Arzneimittelforschung; 1994 Dec; 44(12):1366-8. PubMed ID: 7848359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oroileal transit of slow release 5-aminosalicylic acid.
    Goebell H; Klotz U; Nehlsen B; Layer P
    Gut; 1993 May; 34(5):669-75. PubMed ID: 8504969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical evaluation of salicylazosulfanilic acid as a novel colon-targeted prodrug of 5-aminosalicylic acid.
    Yamaguchi T; Sasaki K; Kurosaki Y; Nakayama T; Kimura T
    J Drug Target; 1994; 2(2):123-31. PubMed ID: 7915179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the plasma pharmacokinetics and faecal excretion of the prodrug olsalazine and its metabolites after oral administration to horses.
    Knoll U; Strauhs P; Schusser G; Ungemach FR
    J Vet Pharmacol Ther; 2002 Apr; 25(2):135-43. PubMed ID: 12000534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
    Sandborn WJ; Hanauer SB; Buch A
    Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 5-aminosalicyltaurine as a colon-specific prodrug of 5-aminosalicylic acid for treatment of experimental colitis.
    Jung Y; Kim HH; Kim H; Kong H; Choi B; Yang Y; Kim Y
    Eur J Pharm Sci; 2006 May; 28(1-2):26-33. PubMed ID: 16455235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of food coadministration on 5-aminosalicylic acid oral suspension bioavailability.
    Yu DK; Elvin AT; Morrill B; Eichmeier LS; Lanman RC; Lanman MB; Giesing DH
    Clin Pharmacol Ther; 1990 Jul; 48(1):26-33. PubMed ID: 2369807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic studies on 5-(7-hydroxy-3-O-phosphonocholyl)aminosalicylic acid for the evaluation of microbial overgrowth.
    Konishi T; Takahashi M; Ohta S
    Biol Pharm Bull; 1997 Apr; 20(4):370-5. PubMed ID: 9145212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.